Madrigal Pharmaceuticals Inc (MDGL)
308.71
+15.30
(+5.21%)
USD |
NASDAQ |
Dec 20, 16:00
307.91
-0.80
(-0.26%)
After-Hours: 20:00
Madrigal Pharmaceuticals Profit Margin (Quarterly): -172.0% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 25.86% |
| 89bio Inc | -- |
| ADMA Biologics Inc | 29.96% |
| Matinas BioPharma Holdings Inc | -- |
| Viking Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -89.04% |
| Return on Assets | -62.73% |
| Return on Invested Capital | -74.25% |
| Gross Profit Margin (Quarterly) | 96.54% |
| Operating Margin (Quarterly) | -187.1% |
| Return on Net Operating Assets | -2.12K% |